Key result
ECT plus benzodiazepines safely resolves neuroleptic malignant syndrome and residual catatonia in four bipolar patients.
Case Report (n=4)
Answers are grounded in this paper and cite their sources.
ECT combined with benzodiazepines appears effective and safe for treating neuroleptic malignant syndrome and residual catatonia in bipolar patients.
We present the history of four bipolar patients who developed neuroleptic malignant syndrome (NMS) after antipsychotic treatment, focusing on the relationship between NMS and catatonia. In all cases, the administration of antipsychotics has been suspended as soon as fever and autonomic disturbances occurred. A supportive therapy was initiated to stabilize general conditions, then every patient started electroconvulsive therapy (ECT) in combination with benzodiazepines (BDZ). The risk of complications was reduced by the quick adoption of supportive care, whereas the combination of ECT and BDZ was effective in resolving the clinical picture. These cases may provide further support to the hypothesis that catatonia and NMS are disorders pertaining to the same spectrum of illness because the onset or exacerbation of catatonic symptoms coincided with the administration of antipsychotics. Our experience confirms the efficacy and safety of ECT in combination with BDZ as treatment of NMS and residual catatonia.
No takes yet. Share an insight, caveat, or question.
Luchini et al. (2012) conducted a case report in Neuroleptic malignant syndrome and catatonia in bipolar disorder (n=4). Electroconvulsive therapy (ECT) in combination with benzodiazepines (BDZ) was evaluated on Resolution of clinical picture. Electroconvulsive therapy in combination with benzodiazepines was effective and safe in resolving neuroleptic malignant syndrome and residual catatonia in four bipolar patients.
Synapse has enriched 10 related papers. Consider them for comparative context: